Replies to post #10279 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"GTCB is far more advanced and closer to a breakthrough on several fronts. I expect a bigger rise than the SIRT one awaits GTCB soon."

I agree but short-term we may be in rough waters for a while. At this stage, it does not look like we will get a partnership announcement before the mailing of the Annual Shareholder meeting Proxy, and that means we can be sure of a Reverse Split request soon. While many argue that an RS is immaterial, I beg to differ and I think such a request will lead to a sell-off even if the RS never gets implemented...

I have been a buyer all along but I am now keeping some powder dry because I think there is a big possibility of us hitting new lows after the Proxy mailing even if that is followed soon after by a major upside. When that happens, I want to be able to pick up some shares at bargain basement prices...

[MTB]

Hi Vin,

Many thanks. I could not agree with you more on the SIRT being ridiculously early stage and speculative. They have very limited data on very early candidates with very little mechanism -- the whole thing is a GIANT leap in the dark -- for 600 million + dollars by BP. For god's sake just drink a glass of red wine :)

In contrast, GTCB has an all but FDA approved drug, a major and significant pipeline of high probability to be approved products, a novel and potentially hugely profitable protein production platform that is a unique play on biosimilars (which will be huge and shortly so0, and reasonable probability blockbuster indications for ATIII in DIC/ CVA with good proposed mechanism . . .

SIRT was a lucky guess -- that I think unlikely to end up being a money maker for BP.

GTCB (despite their immediate lack of funds) has so many potential ways to profit, it still boggles the mind. $600 + million spent by BP here is MUCH more likely to ultimately pay off IMHO -- and yet we bumble along waiting.

A couple of years from now, we'll look back and still be shaking our head that we got in for 60cents/share . . .

Best,
MTB